ArticleFrontiers in oncology2018

Response to HER2 Inhibition in a Patient With Brain Metastasis With EGFR TKI Acquired Resistance and an HER2 Amplification.

Arenda D Meedendorp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.